Science Explorer Back to mapMap
Discussion
Researcher · Advanced Bioscience Laboratories (United States) · United States

Melissa C. Kerzic

Melissa C. Kerzic publishes mostly in Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, on topics such as Immune Cell Function and Interaction, T-cell and B-cell Immunology and Monoclonal and Polyclonal Antibodies Research.

OpenAlex
World rank
#3,267,639
of 7,710,434 ranked researchers
Rank in United States
#925,105
of 1,627,098
Works
22
Citations
759
Citations per work
34.5
h-index
14
i10-index 14Top 52% in Immunology
Melissa C. Kerzic

What does Melissa C. Kerzic research?

Melissa C. Kerzic's work is mostly in Immunology and Microbiology (42%), Medicine (17%), Biochemistry, Genetics and Molecular Biology (8%).

Life Sciences: 11 works · 50.9% of their workImmunology and Microbiology: 9 works · 42.4% of their workImmunology: 9 works · 42.4% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 8.5% of their workMolecular Biology: 2 works · 8.5% of their workEverything else: 4 works · 20.2% of their workHealth Sciences: 4 works · 17.0% of their workMedicine: 4 works · 17.0% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 11.9% of their workHepatology: 1 works · 5.1% of their workPhysical Sciences: 3 works · 11.9% of their workMaterials Science: 1 works · 6.8% of their workMaterials Chemistry: 1 works · 6.8% of their workChemistry: 1 works · 5.1% of their workInorganic Chemistry: 1 works · 5.1% of their workTHEIR WORKMelissa C. Kerzic22works
Life Sciences51%Physical Sciences12%Health Sciences17%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology942.4%
    2. Biochemistry, Genetics and Molecular Biology28.5%
  2. Everything else420.2%
    1. Medicine417.0%
    1. Materials Science16.8%
    2. Chemistry15.1%
  1. 1Immunology42% of their works
  2. 2Radiology, Nuclear Medicine and Imaging12% of their works
  3. 3Molecular Biology8% of their works
  4. 4Materials Chemistry7% of their works
  5. 5Inorganic Chemistry5% of their works
  6. 6Hepatology5% of their works

Research topics

Which keywords describe Melissa C. Kerzic's research?

The keywords of their largest research topics: Foxp3, Glycosylation, Natural Killer Cells, NK Cell Recognition, TGF-ß, Fc Receptors, Therapeutic Antibodies and Immune Response.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Foxp391 topic
  2. Glycosylation92 topics
  3. NK Cell Recognition91 topic
  4. Natural Killer Cells91 topic
  5. TGF-ß91 topic
  6. Fc Receptors71 topic
  7. Therapeutic Antibodies71 topic
  8. Immune Response52 topics
  9. Dendritic Cells31 topic
  10. Hepatitis C Virus31 topic
  11. Immunity31 topic
  12. Treatment31 topic
  13. AIDS21 topic
  14. Cancer21 topic
  15. Glycans21 topic
  16. HIV21 topic
  17. Protein21 topic
  18. Structure21 topic

Where does Melissa C. Kerzic work?

Melissa C. Kerzic's main affiliation in the publication record is Advanced Bioscience Laboratories (United States), United States.

How many publications and citations does Melissa C. Kerzic have?

OpenAlex counts 22 works and 759 citations for Melissa C. Kerzic, an h-index of 14, ranking #3,267,639 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Melissa C. Kerzic. Posts are plain text and can be reported.